- Latest available (Revised)
- Point in Time (29/06/2022)
- Original (As made)
Version Superseded: 30/06/2022
Point in time view as at 29/06/2022. This version of this Instrument contains provisions that are not valid for this point in time.
There are currently no known outstanding effects for the The Novel Foods (Authorisations) and Smoke Flavourings (Modification of Authorisations) (England) Regulations 2022.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Statutory Instruments
Food, England
Made
19th May 2022
Laid before Parliament
20th May 2022
Coming into force in accordance with regulation 1
The Secretary of State makes the following Regulations in exercise of the powers conferred by Articles 12(1) and 32A(3), and in accordance with Articles 9 and 27(1), of Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods, etc. (“Regulation 2015/2283”)(1); and Article 11(4) of Regulation (EC) No. 2065/2003 of the European Parliament and of the Council on smoke flavourings used or intended for use in or on foods(2).
As required by Article 9 of Regulation (EC) No.178/2002 of the European Parliament and of the Council laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety(3), there has been open and transparent public consultation during the preparation and evaluation of these Regulations.
1.—(1) These Regulations may be cited as the Novel Foods (Authorisations) and Smoke Flavourings (Modification of Authorisations) (England) Regulations 2022 and come into force in accordance with paragraphs (2) and (3).
(2) This regulation and regulation 3 come into force on 18th June 2022.
(3) Regulation 2 comes into force on 30th June 2022.
(4) These Regulations extend to England and Wales, but apply in relation to England only.
Commencement Information
I1Reg. 1 in force at 18.6.2022, see reg. 1(2)
Valid from 30/06/2022
2.—(1) The Annex to Commission Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods(4) is amended as follows.
(2) In Table 1—
(a)in the entry for “2’-Fucosyllactose/Difucosyllactose mixture (‘2’-FL/DFL’) (microbial source)”—
(i)in the second column (specified food category) insert “Milk-based drinks and similar products intended for young children”;
(ii)in the third column (maximum levels) insert “1.2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer”;
(b)after the entry for “Schizochytrium sp. (ATCC PTA-9695) oil” insert the entry in Schedule 1;
(c)after the entry for “Schizochytrium sp. (T18) oil” insert the entry in Schedule 2;
(d)after the entry for “Selenium-containing yeast (Yarrowia lipolytica) biomass” insert the entries in Schedule 3.
(3) In Table 2—
(a)for the entry “2’-Fucosyllactose/Difucosyllactose mixture (‘2’-FL/DFL’) (microbial source)” substitute the entry in Schedule 4;
(b)after the entry for “Schizochytrium sp. (ATCC PTA-9695) oil” insert the entry in Schedule 5;
(c)after the entry for “Schizochytrium sp. (T18) oil” insert the entry in Schedule 6;
(d)after the entry for “Selenium-containing yeast (Yarrowia lipolytica) biomass” insert the entries in Schedule 7.
Commencement Information
I2Reg. 2 in force at 30.6.2022, see reg. 1(3)
3.—(1) The Annex to Commission Implementing Regulation (EU) No. 1321/2013 establishing the Union list of authorised smoke flavouring primary products for use as such in or on foods and/or for the production of derived smoke flavourings(5) is amended as follows.
(2) In the entry for unique code “SF-001”—
(a)for “Azelis Denmark A/S” substitute “proFagus GmbH”;
(b)for “Lundtoftegaardsvej 95, 2800 Lyngby, DENMARK” substitute “Uslarer Strasse 30, 37194 Bodenfelde, GERMANY”.
(3) In the entry for unique code “SF-002”—
(a)for “Mastertaste” substitute “Kerry Group plc”;
(b)for “Draycott Mills, Cam, Dursley, Gloucestershire, GL11 5NA, UNITED KINGDOM” substitute “Prince’s Street, Tralee, Co. Kerry, V92 EH11, IRELAND”.
(4) In the entry for unique code “SF-005”—
(a)for “Red Arrow Products Company LLC” substitute “Kerry Group plc”;
(b)for “P.O. Box 1537, 633 South 20th street, Manitowoc, WI 54221-1537, USA” substitute “Prince’s Street, Tralee, Co. Kerry, V92 EH11, IRELAND”.
(5) In the entry for unique code “SF-006”—
(a)for “Red Arrow Products Company LLC” substitute “Kerry Group plc”;
(b)for “P.O. Box 1537, 633 South 20th street, Manitowoc, WI 54221-1537, USA” substitute “Prince’s Street, Tralee, Co. Kerry, V92 EH11, IRELAND”.
(6) In the entry for unique code “SF-007”—
(a)for “Nactis” substitute “J. Rettenmaier @AMP@amp; Söhne GmbH + CO KG”;
(b)for “36, rue Gutenberg – ZI La Marinière, 91070 Bondoufle FRANCE” substitute “Holzmühle 1, 73494 Rosenberg, GERMANY”.
Commencement Information
I3Reg. 3 in force at 18.6.2022, see reg. 1(2)
Maggie Throup
Parliamentary Under-Secretary of State,
Department of Health and Social Care
Valid from 30/06/2022
Regulation 2(2)(b)
Commencement Information
I4Sch. 1 in force at 30.6.2022, see reg. 1(3)
“Schizochytrium sp. strain (FCC-3204) oil | Specified food category | Maximum levels of DHA | The designation of the novel food on the labelling of the foodstuffs containing it is ‘Oil from the microalgae Schizochytrium sp.’. The labelling of food supplements containing Schizochytrium sp. strain (FCC-3204) oil must bear a statement that they should not be consumed by infants and children under the age of 3. |
Food supplements as defined in the Food Supplements (England) Regulations 2003 (6), excluding food supplements for infants and children under the age of 3. | 1000mg/day | ||
Infant formula and follow-on formula as defined in Regulation 609/2013 (7) | In accordance with Regulation 609/2013.” |
Regulation 2(2)(c)
Commencement Information
I5Sch. 2 in force at 30.6.2022, see reg. 1(3)
“Schizochytrium sp. (WZU477) oil | Specified food category | Maximum levels of DHA | The designation of the novel food on the labelling of the foodstuffs containing it is ‘Oil from the microalgae Schizochytrium sp.’. | Included in the list on 30th June 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation 2015/2283. Applicant: Progress Biotech BV of Canaalstaete, Kanaalweg 33, 2903LR Capelle aan den Ijssel, The Netherlands. During the period of data protection, Schizochytrium sp. (WZU477) oil is authorised for placing on the market within England only by Progress Biotech BV unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation 2015/2283 or with the agreement of Progress Biotech BV. The data protection will expire at the end of 29th June 2027. | |
Infant formula and follow-on formula as defined in Regulation 609/2013 | In accordance with Regulation 609/2013.” |
Regulation 2(2)(d)
Commencement Information
I6Sch. 3 in force at 30.6.2022, see reg. 1(3)
“3’-Sialyllactose (3’-SL) sodium salt (microbial source) | Specified food category | Maximum levels [F1(expressed as 3’-Sialyllactose)] | The designation of the novel food on the labelling of the foodstuffs containing it is ‘3’-Sialyllactose sodium salt’. The labelling of food supplements containing 3’-Sialyllactose sodium salt must bear a statement that they should not be consumed: (a) if foods containing added 3’-Sialyllactose sodium salt are consumed the same day (b) by infants and young children. | Included in the list on 30th June 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation 2015/2283. Applicant: Glycom A/S of Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, 3’-Sialyllactose sodium salt is authorised for placing on the market within England only by Glycom A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation 2015/2283 or with the agreement of Glycom A/S. The data protection will expire at the end of 29th June 2027. | |
Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products | 0.25 g/L | ||||
Flavoured fermented milk-based products including heat-treated products | 0.25 g/L (beverages) 2.5g/kg (products other than beverages) | ||||
Unflavoured fermented milk-based products | 0.25 g/L (beverages)
0.5g/kg (products other than beverages) | ||||
Beverages (flavoured drinks, excluding drinks with a pH less than 5) | 0.25 g/L | ||||
Cereal bars | 2.5g/kg | ||||
Infant formula as defined in Regulation 609/2013 | 0.2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
Follow-on formula as defined in Regulation 609/2013 | 0.15 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
Processed cereal-based food and baby food for infants and young children as defined in Regulation 609/2013 | 0.15 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer. 1.25 g/kg for products other than beverages | ||||
Milk-based drinks and similar products intended for young children | 0.15 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
Total diet replacement foods for weight control as defined in Regulation 609/2013 | 0.5 g/L (beverages)
5g/kg (products other than beverages) | ||||
Food for special medical purposes as defined in Regulation 609/2013 | In accordance with the particular nutritional requirements of the persons for whom the products are intended | ||||
Food Supplements as defined the Food Supplements (England) Regulations 2003, excluding food supplements for infants and young children | 0.5 g/day | ||||
6’-Sialyllactose (6’-SL) sodium salt (microbial source) | Specified food category | Maximum levels [F2(expressed as 6’-Sialyllactose)] | The designation of the novel food on the labelling of the foodstuffs containing it is ‘6’-Sialyllactose sodium salt’.
The labelling of food supplements containing 6’-Sialyllactose sodium salt must bear a statement that they should not be consumed: (a) if foods containing added 6’-Sialyllactose sodium salt are consumed the same day (b) by infants and young children. | Included in the list on 30th June 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation 2015/2283. Applicant: Glycom A/S of Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, 6’-Sialyllactose sodium salt is authorised for placing on the market within England only by Glycom A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation 2015/2283 or with the agreement of Glycom A/S. The data protection will expire at the end of 29th June 2027. | |
Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products | 0.5 g/L | ||||
Unflavoured fermented milk-based products | 0.5 g/L (beverages) 2.5g/kg (products other than beverages) | ||||
Flavoured fermented milk-based products including heat-treated products | 0.5 g/L (beverages) 5.0 g/kg (products other than beverages) | ||||
Beverages (flavoured drinks, excluding drinks with a PH less than 5) | 0.5 g/L | ||||
Cereal bars | 5.0 g/kg | ||||
Infant formula as defined in Regulation 609/2013 | 0.4 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
Follow-on formula as defined in Regulation 609/2013 | 0.3 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
Processed cereal-based food and baby food for infants and young children as defined in Regulation 609/2013 | 0.3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer 2.5 g/kg for products other than beverages | ||||
Milk based drinks and similar products intended for young children | 0.3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
Total diet replacement foods for weight control as defined in Regulation 609/2013 | 1.0 g/L (beverages) 10.0 g/kg (products other than beverages) | ||||
Food for special medical purposes as defined in Regulation 609/2013 | In accordance with the particular nutritional requirements of the persons for whom the products are intended | ||||
Food Supplements as defined in the Food Supplements (England) Regulations 2003, excluding food supplements for infants and young children | 1.0 g/day” |
Textual Amendments
Regulation 2(3)(a)
Commencement Information
I7Sch. 4 in force at 30.6.2022, see reg. 1(3)
“2’-Fucosyllactose/Difucosyllactose mixture (‘2’-FL/DFL’) (microbial source) | Description: 2’-Fucosyllactose/Difucosyllactose mixture is a purified, white to off-white powder or agglomerate thereof that is produced by a microbial process. Source: Genetically modified strain of Escherichia coli K-12 DH1 Characteristics/Composition: Appearance: White to off white powder or agglomerates Sum of 2′-Fucosyllactose, Difucosyllactose, D-Lactose, L-Fucose, and 3-Fucosyllactose (% of dry matter): ≥ 92.0 % (w/w) Sum of 2′-Fucosyllactose and Difucosyllactose (% of dry matter): ≥ 85.0 % (w/w) 2′-Fucosyllactose (% of dry matter): ≥ 75.0 % (w/w) Difucosyllactose (% of dry matter): ≥ 5.0 % (w/w) D-Lactose: ≤ 10.0 % (w/w) L-Fucose: ≤ 1.0 % (w/w) 2′-Fucosyl-D-lactulose: ≤ 2.0 (w/w) Sum of other carbohydrates(8) (11): ≤ 6.0 % (w/w) Moisture: ≤ 6.0 % (w/w) Ash, sulfated: ≤ 0.8 % (w/w) pH (20 °C, 5 % solution): 4.0 -6.0 Residual protein: ≤ 0.01 % (w/w) Microbiological criteria: Aerobic mesophilic total plate count: ≤ 1000 CFU/g Enterobacteriaceae: ≤ 10 CFU/g Salmonella sp.: Negative/25 g Yeast: ≤ 100 CFU/g Mould: ≤ 100 CFU/g Residual endotoxins: ≤ 10 EU/mg CFU: Colony Forming Units; EU: Endotoxin Units” |
Regulation 2(3)(b)
Commencement Information
I8Sch. 5 in force at 30.6.2022, see reg. 1(3)
“Schizochytrium sp. strain (FCC-3204) oil | Description/Definition: The novel food is an oil produced from the strain FCC-3204 of the microalgae Schizochytrium sp. Composition: Acid value: ≤ 0.5 mg KOH (potassium hydroxide)/g Peroxide value (PV): ≤ 5.0 meq (milliequivalent)/kg oil Moisture and volatiles: ≤ 0.05 % Unsaponifiables: ≤ 4.5 % Trans-fatty acids: ≤ 1.0 % Docosahexaenoic acid (DHA): ≥ 32.0 % P-anisidine value: ≤ 10” |
Regulation 2(3)(c)
Commencement Information
I9Sch. 6 in force at 30.6.2022, see reg. 1(3)
“Schizochytrium sp. (WZU477) oil | Description/Definition: The novel food is an oil produced from the strain WZU477 of the microalgae Schizochytrium sp. Composition: Acid value: ≤ 0.5 mg KOH (potassium hydroxide)/g Peroxide value (PV): ≤ 5.0 meq (milliequivalent)/kg oil Moisture and volatiles: ≤ 0.05 % Unsaponifiables: ≤ 4.5 % Trans-fatty acids: ≤ 1.0 % Docosahexaenoic acid (DHA): ≥ 32.0 % P-anisidine value: ≤ 10” |
Regulation 2(3)(d)
Commencement Information
I10Sch. 7 in force at 30.6.2022, see reg. 1(3)
“3’-Sialyllactose (3’-SL) sodium salt (microbial source) | Description: 3’-Sialyllactose (3’-SL) sodium salt is a purified, white to off-white powder or agglomerate that is produced by a microbial process and contains limited levels of lactose, 3’-sialyl-lactulose, and sialic acid Source: Genetically modified strain of Escherichia coli K-12 DH1 Definition: Chemical formula: C23H38NO19Na Chemical name: N-Acetyl-α-D-neuraminyl-(2→3)-β-D-galactopyranosyl-(1→4)-D-glucose, sodium salt Molecular mass: 655.53 Da CAS No 128596-80-5 Characteristics/Composition: Appearance: White to off-white powder or agglomerate Sum of 3’-Sialyllactose sodium salt, D-Lactose, and Sialic acid (% of dry matter): ≥ 90.0 % (w/w) 3’-Sialyllactose sodium salt (% of dry matter): ≥ 88.0 % (w/w) D-Lactose: ≤ 5.0 % (w/w) Sialic acid: ≤ 1.5 % (w/w) 3’-Sialyl-lactulose: ≤ 5.0 % (w/w) Sum of other carbohydrates: ≤ 3.0 % (w/w) Moisture: ≤ 8.0 % (w/w) Sodium: 2.5 – 4.5 % (w/w) Chloride: ≤ 1.0 % (w/w) pH (20 °C, 5 % solution): 4.5 -6.0 Residual protein: ≤ 0.01 % (w/w) Microbiological criteria: Aerobic mesophilic bacteria total plate count: ≤ 1000 CFU/g Enterobacteriaceae: ≤ 10 CFU/g Salmonella sp.: Absence in 25 g Yeast: ≤ 100 CFU/g Mould: ≤ 100 CFU/g Residual endotoxins: ≤ 10 EU/mg CFU: Colony Forming Units; EU: Endotoxin Units |
6’-Sialyllactose (6’-SL) sodium salt (microbial source) | Description: 6’-Sialyllactose (6’-SL) sodium salt is a purified, white to off-white powder or agglomerate that is produced by a microbial process and contains limited levels of lactose, [F36’-sialyl-lactulose], and sialic acid Source: Genetically modified strain of Escherichia coli K-12 DH1 Definition: Chemical formula: C23H38NO19Na Chemical name: N-Acetyl-α-D-neuraminyl-(2→6)-β-D-galactopyranosyl-(1→4)-D-glucose, sodium salt Molecular mass: 655.53 Da CAS No 157574-76-0 Characteristics/Composition: Appearance: White to off-white powder or agglomerate Sum of 6’-Sialyllactose sodium salt, D-Lactose and Sialic acid (% of dry matter): ≥ 94.0 % (w/w) 6’-Sialyllactose sodium salt (% of dry matter): ≥ 90.0 % (w/w) D-Lactose: ≤ 5.0 % (w/w) Sialic acid: ≤ 2.0 % (w/w) 6’-Sialyl-lactulose: ≤ 3.0 % (w/w) Sum of other carbohydrates: ≤ 3.0 % (w/w) Moisture: ≤ 6.0 % (w/w) Sodium: 2.5-4.5 % (w/w) Chloride: ≤ 1.0 % (w/w) pH (20 °C, 5 % solution): 4.5-6.0 Residual protein: ≤ 0.01 % (w/w) Microbiological criteria: Aerobic mesophilic bacteria total plate count: ≤ 1 000 CFU/g Enterobacteriaceae: ≤ 10 CFU/g Salmonella sp.: Absence in 25 g Yeast: ≤ 100 CFU/g Mould: ≤ 100 CFU/g Residual endotoxins: ≤ 10 EU/mg CFU: Colony Forming Units; EU: Endotoxin Units” |
Textual Amendments
(This note is not part of the Regulations)
Regulation 2 amends Commission Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods to add four novel foods and amend the conditions of use and specifications of one novel food on the list of authorised novel foods.
Regulation 3 amends Commission Implementing Regulation (EU) No. 1321/2013 establishing the Union list of authorised smoke flavouring primary products for use as such in or on foods and/or for the production of derived smoke flavourings to modify the authorisation holder and addresses for five smoke flavouring primary product authorisations.
An impact assessment has not been produced for this instrument as no, or no significant, impact on the public, private or voluntary sector is foreseen.
EUR 2015/2283, amended by S.I. 2019/702. The terms “prescribe” and “appropriate authority” are defined in Article 3.
EUR 2003/2065, amended by S.I. 2019/860. The terms “prescribe” and “appropriate authority” are defined in Article 3.
EUR 2002/178, amended by S.I. 2019/641.
EUR 2017/2470, amended by S.I. 2019/702.
EUR 2013/1321, amended by S.I. 2019/860.
S.I. 2003/1387, to which there are amendments not relevant to these Regulations.
EUR 2013/609, amended by S.I. 2019/651.
2’-Fucosyl-galactose, Glucose, Galactose, Mannitol, Sorbitol, Galactitol, Trihexose, Allo-lactose and other structurally related carbohydrates.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: